DPIIT recognised startup Government of India
Startup India
Sprygen Biotherapeutics Private Limited
Sprygen Biotherapeutics Private Limited - research & development in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹100
Latest filing
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Brands
1
Associated brands
Last financials
Mar 2024
Balance sheet date
Last AGM
05 Sep 2024
Annual general meeting
About Sprygen Biotherapeutics Private Limited
Data last updated:
Sprygen Biotherapeutics Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the research and development sector. It was incorporated on 10 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U85100KA2020PTC131489.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Caartigen Biotherapeutics Private Limited. It is led by directors Sujatha Shrinivas and Natarajan Essakimuthu.
Its last annual general meeting (AGM) was held on 05 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.677 1st Floor 27th Main 13th Cross Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
The company is associated with 1 brand: Caartigen.
Company details
CIN U85100KA2020PTC131489
Registration Number 131489
Incorporation Date 10 January 2020
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 05 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Sprygen Biotherapeutics
Contact details
Sprygen Biotherapeutics Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.677 1st Floor 27th Main 13th Cross Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryResearch & Development, Research & Development
To see the full contact details of Sprygen Biotherapeutics Private Limited, buy the company report.
Comprehensive company report
Sprygen Biotherapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sprygen Biotherapeutics operates one associated brand: Caartigen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers comprehensive stem cell and PRP treatments for orthopedic conditions. | caartigen.com |
Business activity
The main business activity of Sprygen Biotherapeutics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Sprygen Biotherapeutics Private Limited, buy the company report.
Financials of Sprygen Biotherapeutics Private Limited
FY 2024 filings availableSprygen Biotherapeutics Private Limited reported revenue of ₹100 for FY 2024.
Revenue · FY 2024
₹100
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹100 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sprygen Biotherapeutics Private Limited, buy the company report.
Board of directors of Sprygen Biotherapeutics Private Limited
Sprygen Biotherapeutics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujatha Shrinivas | Director | 10 Jan 2020 | 6 Years 9 Months | Current |
| Natarajan Essakimuthu | Director | 10 Jan 2020 | 6 Years 9 Months | Current |
Peer comparison
Sprygen Biotherapeutics Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bajia Brothers Private Limited | ₹186 (FY 2022) | -100.0% | Jaipur, Rajasthan, India | |||
| Auro Speciality Chemicals Private Limited | ₹176 (FY 2025) | -100.0% | Hyderabad, Telangana, India | |||
| Ampsers Technologies (OPC) Private Limited | ₹172 (FY 2022) | Hyderabad, Telangana, India | ||||
| New View Research and Development Private Limited | ₹118 (FY 2025) | Chandrapur, Maharashtra, India | ||||
| Sprygen Biotherapeutics Private Limitedthis company | ₹100 (FY 2024) | Bangalore, Karnataka, India | ||||
| Urban Vertical & Integrated Box Ecosystem Private Limited | ₹100 (FY 2020) | Navi Mumbai, Maharashtra, India | ||||
| Suepravision Life Sciences Private Limited | ₹10 (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Helikem Biotek Industrial Research Private Limited | ₹7 (FY 2025) | -100.0% | Tiruchirappalli, Tamil Nadu, India | |||
| Council for Strategic Affairs | ₹1 (FY 2025) | Rohtak, Haryana, India |
To see the full peer comparison of Sprygen Biotherapeutics Private Limited, buy the company report.
Auditor
Sprygen Biotherapeutics Private Limited is audited by RM. KANNAN for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RM. KANNAN | FY 2024 | 202315 |
Shareholding
The shareholding of Sprygen Biotherapeutics Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Sprygen Biotherapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sprygen Biotherapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sprygen Biotherapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sprygen Biotherapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sprygen Biotherapeutics Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Natarajan Essakimuthu was appointed as Director on 10 Jan 2020.
AGM
Sprygen Biotherapeutics Private Limited last Annual general meeting of members was held on 05 Sep 2024 as per latest MCA records.
Filing
Sprygen Biotherapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Appointed
Natarajan Essakimuthu was appointed as Director.
Appointed
Sujatha Shrinivas was appointed as Director.
Incorporation
10 Jan 2020
Sprygen Biotherapeutics Private Limited was registered on 10 Jan 2020 with Roc Bangalore & aged 6 years 9 months as per MCA records.
Frequently asked questions
Sprygen Biotherapeutics is an active private limited company based in Bangalore, Karnataka, India. The company works in the research and development industry. It was incorporated on 10 January 2020 (6+ years old) and is registered under CIN U85100KA2020PTC131489.
Sprygen Biotherapeutics has 2 current directors:
- Sujatha Shrinivas - Director
- Natarajan Essakimuthu - Director
The latest financial statements of Sprygen Biotherapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 05 September 2024. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Sprygen Biotherapeutics is U85100KA2020PTC131489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sprygen Biotherapeutics was incorporated on 10 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Sprygen Biotherapeutics by revenue are Bajia Brothers Private Limited, Auro Speciality Chemicals Private Limited, Ampsers Technologies (OPC) Private Limited, New View Research and Development Private Limited, Urban Vertical & Integrated Box Ecosystem Private Limited and 3 more, all in the same principal business activity (scientific research and development).
Natarajan Essakimuthu was appointed as Director on 10 Jan 2020. Sujatha Shrinivas was appointed as Director on 10 Jan 2020.
Yes, Sprygen Biotherapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Sprygen Biotherapeutics is at No.677 1st Floor 27th Main 13th Cross Sector 1 Hsr Layout, Bangalore, Karnataka, India – 560102.
Sprygen Biotherapeutics operates in the research and development industry.
Sprygen Biotherapeutics has 1 associated brand: Caartigen.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages